Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.44 EUR | +1.61% | +7.65% | -51.74% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
05-14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.74% | 1.97B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Transcript : Evotec SE, Q1 2022 Earnings Call, May 11, 2022